Aug 19, 2024 CASGEVY: CRISPR/Cas9 gene therapy now available in England following NICE recommendation By Claire Smith Luca Cericola Vertex Pharmaceuticals announced a reimbursement agreement with NHS England for individuals 12 years or older with transfusion-dependent...
Aug 05, 2024 Podcast: Open source - audit, valuation and deals By Anneke Pol Toby Crick Originally recorded and released in March 2023, this episode of The Roadmap sees Anneke Pol and Toby Crick discuss open source software...
Jul 04, 2024 What employers need to know about the EU AI Act By Emily Atkinson Uses of AI systems in an employment context are to be tightly regulated by the AI Act given the potentially significant impact their use...
Jul 04, 2024 Copyright issues under the EU AI Act By Toby Headdon Intellectual property is one of the main issues for everyone involved in the burgeoning AI ecosystem. The large generative AI model...
Jul 04, 2024 The EU AI Act as product safety legislation – lessons from the world of medical devices By Alex Denoon An AI system is classified as “high-risk”, the AI Act imposes significant requirements on the provider in order for it to place the...
Jul 04, 2024 Are data protection governance frameworks a good model for AI governance? By Marc Dautlich What feels really British but isn’t? “Almost everything in the British Museum” goes the old gag. Could a similar analogy be made about...
Jul 04, 2024 What is my role under the AI Act? By Charlie Hawes If your AI system might be “high-risk” under the AI Act, the next question to ask is what role(s) and associated responsibilities does my...
Jul 04, 2024 Navigating the EU AI Act: what you need to know By Vik Khurana Charlie Hawes The EU AI Act is a game-changing AI regulatory framework that will be significant for organisations inside and outside the AI industry....
Jul 03, 2024 The Future of UK PIs – Cyanamid, Skat and injunction creep By Claire Phipps-Jones This article was first published in Kluwer Patent Blog [July, 2024]. The recent rivaroxaban PI cases may have caused you to ask yourself...